Reza Asari
- Surgery top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Physiology top 10%
- Co-authors
- Sebastian F. SchoppmannBruno NiederleMatthias PairederChristian ScheubaOskar KoperekIvan KristoAhmed Ba‐SsalamahKlaus Kaserer
- Topics
- Esophageal and GI Pathology (27 papers)Esophageal Cancer Research and Treatment (24 papers)Gastric Cancer Management and Outcomes (18 papers)
- Journals
- SHILAP Revista de lepidopterologíaGastroenterologyAnnals of Surgery
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Reza Asari
64 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 85
- Surgery 1.1k
- Endocrinology, Diabetes and Metabolism 608
- Oncology 417
- Pulmonary and Respiratory Medicine 311
- Physiology 302
Countries citing papers authored by Reza Asari
This map shows the geographic impact of Reza Asari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Asari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Asari more than expected).
Fields of papers citing papers by Reza Asari
This network shows the impact of papers produced by Reza Asari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Asari. The network helps show where Reza Asari may publish in the future.
Co-authorship network of co-authors of Reza Asari
This figure shows the co-authorship network connecting the top 25 collaborators of Reza Asari. A scholar is included among the top collaborators of Reza Asari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Asari. Reza Asari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 32 | |
| 6 | 24 | |
| 7 | 1 | |
| 8 | 27 | |
| 9 | 176 | |
| 10 | 8 | |
| 11 | Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. | 3 |
| 12 | 11 | |
| 13 | 38 | |
| 14 | 21 | |
| 15 | 40 | |
| 16 | 19 | |
| 17 | 31 | |
| 18 | 9 | |
| 19 | 33 | |
| 20 | 32 |
About Reza Asari
Reza Asari is a scholar working on Gastroenterology, Speech and Hearing and Surgery, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Esophageal and GI Pathology (27 papers), Esophageal Cancer Research and Treatment (24 papers) and Gastric Cancer Management and Outcomes (18 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (608 citations), Nephrology (229 citations) and Geriatrics and Gerontology (122 citations). Reza Asari has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Sebastian F. Schoppmann, Bruno Niederle, Matthias Paireder, Christian Scheuba, Oskar Koperek, Ivan Kristo, Ahmed Ba‐Ssalamah, Klaus Kaserer, Dietmar Tamandl and Matthias Preusser. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.